BridgeMD
Pooled human plasma vs. Crystalloid in the fluid management of children undergoing instrumented spinal fusion for scoliosis. A double-blind, randomized clinical trial.
EU CTIS ID: 2024-514857-31-00
What this study is testing
To quantify the efficacy of OCTAPLAS infusion to reduce intraoperative blood loss compared with PLASMALYTE in subjects undergoing PSF for scoliosis.
- Therapeutic exploratory (Phase II)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Scoliosis patients (aged 10 to 21 years of age) undergoing posterior spinal fusion for adolescent idiopathic scoliosis or neuromuscular scoliosis (>45 degrees) using pedicle screw technique.
You likely can't join if
- Coagulation disorder, smoking, unwilling to consent, vertebral column resection, need for anteroposterior surgery and body mass index over 40.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.